These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23921231)

  • 1. Targeting the Wnt pathway in synovial sarcoma models.
    Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
    Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex.
    Pretto D; Barco R; Rivera J; Neel N; Gustavson MD; Eid JE
    Oncogene; 2006 Jun; 25(26):3661-9. PubMed ID: 16462762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
    Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
    Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.
    Saito T
    Int J Clin Exp Pathol; 2013; 6(11):2272-9. PubMed ID: 24228088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
    Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
    Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of SYT-SSX fusion gene in paraffin-embedded tissues and its clinicopathologic significance for synovial sarcoma].
    Wei Y; Sun M; Zhu H; Xu Z; Wang J; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):426-30. PubMed ID: 11866984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells.
    Hayakawa K; Ikeya M; Fukuta M; Woltjen K; Tamaki S; Takahara N; Kato T; Sato S; Otsuka T; Toguchida J
    Biochem Biophys Res Commun; 2013 Mar; 432(4):713-9. PubMed ID: 23313505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma.
    Cai W; Sun Y; Wang W; Han C; Ouchida M; Xia W; Zhao X; Sun B
    Pathol Oncol Res; 2011 Jun; 17(2):357-67. PubMed ID: 21234732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
    Wei Y; Wang J; Zhu X; Shi D; Hisaoka M; Hashimoto H
    Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma.
    Cironi L; Petricevic T; Fernandes Vieira V; Provero P; Fusco C; Cornaz S; Fregni G; Letovanec I; Aguet M; Stamenkovic I
    Sci Rep; 2016 Feb; 6():22113. PubMed ID: 26905812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and analysis of SYT-SSX fusion gene in synovial sarcoma].
    Xu Z; Yang T; Wu B; Zhong H; Yang Z; Zhou B; Zhang C; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):431-3. PubMed ID: 11866985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
    Xie Y; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
    Cancer Res; 2002 Jul; 62(13):3861-7. PubMed ID: 12097301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SYT-SSX fusion genes in synovial sarcoma of the thorax.
    Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
    Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusions of the SYT and SSX genes in synovial sarcoma.
    Ladanyi M
    Oncogene; 2001 Sep; 20(40):5755-62. PubMed ID: 11607825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2.
    Garcia CB; Shaffer CM; Eid JE
    BMC Genomics; 2012 May; 13():189. PubMed ID: 22594313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma.
    Ishida M; Miyamoto M; Naitoh S; Tatsuda D; Hasegawa T; Nemoto T; Yokozeki H; Nishioka K; Matsukage A; Ohki M; Ohta T
    Mol Cell Biol; 2007 Feb; 27(4):1348-55. PubMed ID: 17101797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.